While Johnson & Johnson retains the top revenue rank across the major pharma companies, Eli Lilly last year established ...

Collegium Pharma announced a $650M cash acquisition of AZSTARYS, aiming to boost ADHD portfolio synergies and pro forma sales ...

Tonix Pharmaceuticals Holding Corp. TNXP shares are up during Friday’s premarket session as the company recently reported its ...

2025 might shape out to be a boon year for pharma, a recent report from Norstella’s Evaluate suggests. The 2025 Preview Report examines the “biggest movers and shakers” in the biotech and pharma ...

Even with Inflation Reduction Act (IRA)-related pressure looming for its top product, Teva Pharmaceuticals is continuing to deliver on the “Pivot to Growth” strategy CEO Richard Francis had envisioned ...

Ascentage Pharma reported 2024 sales of $134.3M, up 342% YoY, driven by a $100M option payment from Takeda under an exclusive agreement. JP Morgan initiated Ascentage Pharma with an Overweight rating ...

Q4 2025 Management View Richard Lowenthal, Co-Founder, President, CEO & Director, highlighted that "2025 was our first full year for ARS as a commercial company. It was a year focused on building ...

The primary growth drivers in Bayer’s pharma sector—Nubeqa and Kerendia—are performing even better than the company anticipated and their momentum is expected to continue in 2026. But that won’t lead ...

LONDON--(BUSINESS WIRE)--As coronavirus continues to wreak havoc across industries, Quantzig’s sales analytics experts analyze the recent challenges in the pharmaceutical industry and explain why a ...

Pharma Foods International Co., Ltd. ( (JP:2929)) just unveiled an announcement. Pharma Foods International Co., Ltd. reported its consolidated financial results for the three months ended October 31, ...

In 2025, Amarin's net loss per share was $0.09, significantly better than the $0.20 reported in 2024. This progress, despite ...